Parkwalk Advisors spearheaded the round to help the medical technology company prepare for human trials.
"With the support of our investors, we are on the cusp of revolutionising brain aneurysm treatment. Our team is dedicated to working with regulators, medical professionals, and industry experts to bring this product to market and address a condition impacting countless individuals worldwide."
The Series A round was led by Mustard Seed Partners to support network expansion and recruitment.
"The first years of a child’s development are absolutely crucial for shaping their long-term educational trajectory. Early years educators play an enormous role in this, but astronomical costs and provider shortages have robbed too many families of access to high quality care. That’s why we’re working to reverse the decline in childminder numbers – the most affordable form of childcare – and champion those who want to pursue a hugely rewarding role. Our success is proof that there’s a huge appetite for careers in early years when the right support is on offer. We’re finding the next generation of childminders and securing the futures of the next generation of children."
The Series A round was led by Octopus Ventures with backing from angels and institutional investors.
"Before we built Definely, lawyers that needed to access information and understand contracts would use Ctrl+F keys, multiple windows, scroll through hundreds of pages, or simply print out documents so that they could reference all the information in one place. As someone who is visually impaired, you can imagine the challenge this represented for me."